Research map: Trapped in “No Man’s Land”: Navigating clinical trial enrollment as an adult with a WHO Grade 4 pediatric-type glioma

Back to the article

Papers in this map

  1. Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification · Francesca Gianno · 2022 · 64 citations · Cited by this paper
  2. Cognitive dysfunction associated with cellular immunotherapy for cancer · 2026 · Related
  3. A review of diffuse hemispheric glioma, H3 G34-mutant disease development, DNA repair, microenvironment, and treatments on the horizon · Cameron Crowell · 2025 · 5 citations · Cited by this paper
  4. The molecular profile of gliomas in adolescents and young adults · 2026 · Related
  5. Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors · Wenlin Chen · 2023 · 4 citations · Cited by this paper
  6. Immunogenomic Profiling Reveals Targets for Gene Therapy in Pediatric Brain Tumors · 2026 · Related
  7. Emotional distress impairs immune checkpoint blockade efficacy in recurrent high-grade glioma: Insights from tumor in situ fluid analysis · 2026 · Related
  8. Mutational signature stratification of recurrent gliomas reveals distinct patterns of genomic traits · 2026 · Related
  9. Emerging blood-based biomarkers for the detection of parenchymal brain metastasis: Current progress and future perspectives · 2026 · Related
  10. ASL-based Exchange Time Mapping for Differentiation of High-Grade Glioma and Brain Metastases · 2026 · Related
  11. Disturbance of functional connectivity in patients with low grade glioma is associated with worse progression–free survival · 2026 · Related
  12. The Cell Surface Proteome of Malignant Peripheral Nerve Sheath Tumors Reveals Therapeutic Targets · 2026 · Related
  13. Phase I Trial and Pharmacokinetic Study of Berubicin (RTA 744) in Patients with Recurrent or Refractory High-Grade Gliomas · 2026 · Related

Source: OpenAlex (CC0)